# Patient Communication in Substance Use Disorders

Use nonjudgmental, person-centered communication to identify treatment goals, address ambivalence, reduce stigma, and connect patients with substance use disorders to evidence-based medications, behavioral treatment, harm reduction, and longitudinal follow-up.

**Clinical question:** How should physicians communicate with patients who have substance use disorders to improve engagement, treatment uptake, and retention?

Updated: 2026-08-21T02:25:54.253843+00:00

## What matters in practice
- Use person-first, nonjudgmental language and avoid stigmatizing labels; clinician attitudes can adversely affect care delivery and treatment engagement. [1][8]
- For ambivalence about changing use or accepting treatment, use motivational interviewing: explore the patient’s reasons for change, avoid argument, and support self-efficacy. [10][11]
- Make treatment goals and modality selection patient-driven while giving clear clinical advice; matching preferred treatment options can improve alcohol and drug-related outcomes. [13]
- Pair intrinsic-motivation strategies such as motivational interviewing with contingency management when objective reinforcement of attendance, toxicology targets, or other recovery behaviors is feasible. [12][22]
- For opioid use disorder, communication should explicitly offer medication treatment and address overdose prevention, withdrawal, pain, psychosocial needs, stigma, and post-discharge linkage. [12][24]

## Set a nonjudgmental frame before assessing readiness

Communication during the first encounter determines whether assessment leads to disclosure and a next treatment step.

Open with the patient’s priorities rather than a demand for abstinence: ask what they value, what concerns them about current use, and what outcome they would consider worth pursuing today. State that the visit can address safer use, reduced use, abstinence, medication treatment, withdrawal concerns, or linkage to care. A client-driven goal process is consistent with motivational interviewing, and matching patients to preferred substance use disorder treatment options can improve alcohol and drug-related outcomes. [13]

Use person-first language, including “person with opioid use disorder,” “person who uses drugs,” and “substance use disorder,” rather than labels such as “addict,” “abuser,” or “clean/dirty.” Healthcare professionals’ negative attitudes toward addiction can adversely affect service delivery, whereas knowledge dissemination and respectful language are identified strategies to counter stigma in clinical settings. [1][8]

When trauma, prior coercive treatment, discrimination, or mistrust may be affecting engagement, make the encounter explicitly collaborative: explain choices, ask permission before sensitive questions, offer options rather than ultimatums, and identify what would make treatment feel safe. Trauma-informed care emphasizes shared decision-making, trust, empowerment, and culturally and linguistically appropriate care. [24]
- Start with an agenda-setting question: “What would be most helpful to change about your substance use or its consequences?” [10][13]
- Ask permission before offering education: “Would it be okay if I shared what treatment options can help with that?” This preserves collaboration while allowing direct medical advice. [10][13]
- Use the patient’s stated goal in the plan and document the next action before the visit ends, such as medication discussion, behavioral referral, harm-reduction planning, or a scheduled reassessment. [13][24]

*Communication choices that either preserve or undermine treatment engagement. [1][8][10][11][24]*

| Clinical task | Use | Avoid | Immediate next step |
| --- | --- | --- | --- |
| Elicit substance-use history | “Can you tell me what role alcohol or drugs are playing for you lately?” [10] | Confrontational questioning or moral framing, which can increase resistance. [11] | Reflect the patient’s stated concern and ask which consequence they most want to address. [10][11] |
| Discuss a positive screen or suspected disorder | “This result suggests substance use may be affecting health. What do you make of it?” [10][11] | Treating a screening result as proof of unwillingness or dishonesty. | Assess the patient’s interpretation, goals, and interest in treatment options. [13] |
| Offer treatment | “There are medication, counseling, and recovery-support options; we can choose an approach that fits your goals.” [12][13] | Presenting abstinence or one program as the only acceptable outcome. | Provide a recommendation, then elicit preference and barriers to starting. [13] |
| Address prior trauma or stigma | “You deserve respectful care. What has made healthcare or treatment difficult in the past?” [24] | Assuming nonadherence reflects lack of motivation. | Use shared decisions, clarify confidentiality boundaries, and arrange an acceptable follow-up pathway. [24] |

## Use motivational interviewing when the patient is uncertain about change

Motivational interviewing is most useful when the clinician needs to convert ambivalence into a patient-owned next action.

Motivational interviewing is a collaborative, goal-oriented communication style that focuses on change language. Its purpose is to strengthen personal motivation and commitment by exploring the patient’s own reasons for change and resolving ambivalence in an accepting, compassionate interaction. [10]

Prioritize four actions: express empathy, develop discrepancy between the patient’s goals and the effects of use, avoid argument or confrontation, and support self-efficacy. Motivational enhancement therapy uses these motivational interviewing techniques while monitoring progress toward patient-expressed goals. [11]

Listen for both change talk and sustain talk. When a patient says, “I know methamphetamine is affecting work, but it is the only way I can function,” reflect both sides before advising: “Work matters to you, and you are worried the current pattern is costing you the stability you want.” Then ask an evoking question: “What would be different if use were less in control of your workday?” This approach is designed to guide rather than impose an expert conclusion. [4][10]

End a brief intervention with a concrete, patient-selected plan rather than an open-ended recommendation. The plan can be a treatment appointment, a medication conversation, a recovery-support contact, a harm-reduction step, or a follow-up visit to reassess readiness. Brief interventions using motivational interviewing can be delivered by trained healthcare personnel, including in integrated HIV care settings. [8][13]
- Ask open questions: “What concerns you most about continuing this pattern?” “What would make treatment worth trying?” [10][11]
- Use reflective statements before information-giving: “You are not sure abstinence is realistic, but avoiding another overdose matters to you.” [10]
- Ask for permission before advice, then use elicit-provide-elicit: ask what the patient knows, provide concise information, and ask what it means for their decision. [10][13]
- Convert confidence into planning: “What is one step you would be willing to take before our next visit?” [11][13]

### When to move beyond a brief motivational intervention

Do not repeatedly use motivational interviewing as a substitute for indicated treatment. If the patient identifies a goal and is ready to act, transition promptly to the appropriate medication, behavioral treatment, overdose-prevention intervention, or level-of-care assessment. For opioid use disorder, medication is described as the most effective treatment and standard of care; counseling can complement medication but should not be positioned as a prerequisite to medication access. [12]

Use a more structured behavioral pathway when motivational work has not produced sustained engagement. Motivational interviewing and motivational enhancement therapy can improve retention and adherence for some substances, particularly among people entering treatment with low motivation to change. [22]

*Brief motivational interviewing sequence for a routine medical encounter. [10][11][13]*

| Step | Physician action | Decision produced |
| --- | --- | --- |
| Engage | Ask what the patient wants from the visit and reflect their concern without judgment. [10] | Whether the patient will discuss use and related consequences. |
| Focus | Negotiate one target: use pattern, overdose risk, medication treatment, attendance, or another patient-defined consequence. [13] | A shared agenda rather than a clinician-imposed objective. |
| Evoke | Ask for reasons, importance, and confidence regarding a specific change; reflect change talk. [10][11] | The patient’s own rationale and barriers. |
| Plan | Offer options, make a specific next-step plan, and arrange follow-up. [13][24] | A measurable action that can be reviewed at the next encounter. |

## Use shared decisions to convert concern into treatment initiation

A recommendation is necessary; shared decision-making determines how that recommendation becomes feasible for this patient.

Present treatment as a menu linked to the patient’s stated goal: medication, counseling, contingency management, recovery support, care coordination, or a combination. Explain the expected target of each option and ask which option feels acceptable now. Client-driven goal clarification and matching to preferred treatment options can reduce alcohol consumption and improve drug-related outcomes. [13]

For opioid use disorder, explicitly discuss medication treatment rather than limiting the conversation to counseling or referral. Medication is described as the most effective treatment and standard of care for opioid use disorder, and hospitalized care models that improve treatment initiation address opioid use, withdrawal, pain, psychosocial issues, overdose prevention, and linkage to post-discharge care. [12][24]

When the patient declines a recommended option, identify the specific barrier: fear of withdrawal, prior adverse treatment experience, cost, transportation, confidentiality, housing instability, legal concerns, family conflict, or concern about stigma. Respond by modifying the access plan rather than interpreting refusal as lack of motivation. Trauma-informed approaches emphasize empowerment and trust, while integrated models use motivational interviewing, psychoeducation, harm reduction, and case-management support to address ambivalence and disempowerment. [24]

Use family involvement only with the patient’s permission and when it supports the patient’s goals. For adolescents and young adults with alcohol use or alcohol use disorder with or without other drug use, guideline-supported options include non-brief motivational interviewing, family therapy, and cognitive-behavioral therapy. [3]
- Name the recommendation directly: “Given your opioid use disorder and overdose risk, I recommend medication treatment today; we can also add counseling if that is useful to you.” [12][24]
- Ask the implementation question: “What would get in the way of starting this in the next few days?” [13][24]
- Schedule the next contact before the patient leaves when initiating a treatment or linkage plan; treatment-engagement strategies are intended to reduce early dropout. [22][24]

*Match communication to the treatment decision being made. [3][12][13][24]*

| Patient stance | Communication priority | Action after the discussion |
| --- | --- | --- |
| Ready to reduce or stop use | Affirm readiness, provide options, and make a specific implementation plan. [13] | Initiate or link to the selected treatment without delaying for repeated motivational work. [12][24] |
| Ambivalent about treatment | Elicit personally meaningful reasons for change and explore barriers without argument. [10][11] | Agree on one low-barrier next step and reassess readiness at follow-up. [13] |
| Declines abstinence-oriented care | Separate the patient’s current goal from access to care; discuss safer-use and overdose-prevention priorities. [24] | Maintain follow-up and re-offer medication and behavioral options at subsequent encounters. [12][24] |
| Adolescent or young adult | Assess whether family participation would support the patient’s goals and confidentiality needs. [3] | Offer motivational interviewing, family therapy, or cognitive-behavioral therapy as clinically appropriate. [3] |

## Use contingency management for objective treatment targets

Contingency management adds external reinforcement when motivation alone has not produced attendance, abstinence, or other recovery behaviors.

Contingency management provides incentives contingent on a predefined behavior. It is among the most effective behavioral interventions for problematic substance use and is used most often for stimulant recovery, including cocaine, methamphetamine, and prescription stimulant use, although it can be used for other substances. [12]

Specify the target behavior before enrollment: treatment attendance, medication adherence, toxicology-confirmed abstinence, engagement in prosocial activities, or another recovery behavior. Contracts and reinforcement schedules are commonly used in programs that employ contingency management; incentives may reinforce substance-free toxicology results or other agreed targets. [13][23]

Use contingency management as a complement rather than a replacement for patient-centered counseling. Motivational interviewing relies on intrinsic motivation, whereas contingency management relies on extrinsic incentives. Both approaches can reduce use across a range of substances; evidence summarized in motivational treatment guidance suggests extrinsically focused strategies may have shorter-term effects, while intrinsic motivation may be more important for maintaining behavior change. [12][22]

For patients receiving cognitive-behavioral therapy, consider whether a program can combine motivational enhancement, contingency management, and cognitive-behavioral skills work. Motivational strategies at the beginning of cognitive-behavioral therapy can improve motivation and retention, and studies of combined cognitive-behavioral therapy plus contingency management have found greater abstinence after treatment. [12]
- Make the contingency transparent: identify the behavior, verification method, timing, incentive, and what happens after a missed target. [13][23]
- Avoid punitive framing. State that incentives are designed to reinforce recovery behaviors, not to test whether the patient deserves care. [12][23]
- Continue to address relapse triggers, coping skills, and setbacks; relapse-prevention counseling is a cognitive-behavioral approach to identifying triggers, managing them, and strengthening self-efficacy. [22]

*Select behavioral communication strategies by the barrier to change. [10][12][22][23]*

| Primary barrier | Preferred communication approach | Operational target |
| --- | --- | --- |
| Ambivalence or low confidence | Motivational interviewing or motivational enhancement therapy. [10][11] | Patient-defined next step, treatment attendance, or a change plan. [13] |
| Poor attendance or inconsistent engagement | Contingency management plus collaborative barrier assessment. [12][23] | Verified visits or treatment participation. [23] |
| Stimulant use with need for abstinence reinforcement | Contingency management within a broader treatment plan. [12] | A predefined, objectively monitored abstinence target. [13][23] |
| Recurrent use after initial stabilization | Relapse-prevention counseling with motivational reinforcement. [22] | Identification of triggers, coping practice, and a response plan for setbacks. [22] |

## Make follow-up communication part of treatment, not an administrative afterthought

The first plan is provisional; follow-up should test whether access, fit, and retention barriers have changed.

At each follow-up, review the action selected at the prior encounter, not only the amount of substance used. Ask whether the patient was able to start the chosen treatment, what barriers emerged, whether the goal remains meaningful, and whether the plan needs to change. Motivational approaches support ongoing monitoring of progress toward patient-expressed goals. [11][13]

Respond to recurrence of use with a reassessment of triggers, treatment fit, access barriers, and safety needs rather than a discharge-oriented conversation. Relapse-prevention counseling focuses on identifying and managing triggers, developing coping skills, strengthening self-efficacy, and managing setbacks. [22]

Build communication capacity at the practice level. Provider-stigma interventions have included online education, in-person education, communication training, mentorship, and contact with people in recovery; higher-quality studies incorporated motivational interviewing or communication training, and consumer-contact interventions demonstrated longer-term effects. [1]

Where substance use intersects with chronic disease care, integrate rather than silo the conversation. In HIV care, integration of substance use treatment with HIV care is considered ideal, and trained personnel can provide brief interventions that include motivational interviewing. [8]
- Use a follow-up question that detects implementation failure: “What happened when you tried to carry out the plan we made?” [11][13]
- If the patient did not start treatment, identify one modifiable obstacle and revise the plan during the same visit. [24]
- If the patient did start treatment, reinforce the behavior specifically and ask what would help sustain it through the next interval. [22]

*Follow-up prompts tied to common treatment-engagement decisions. [11][13][22][24]*

| Follow-up finding | Targeted question | Next action |
| --- | --- | --- |
| Did not attend referral | “What made the appointment hard to complete?” [24] | Address the named logistical, stigma-related, or trust-related barrier and arrange a revised linkage plan. [24] |
| Continued use despite stated goal | “What was happening before you used, and what did you need in that moment?” [22] | Use relapse-prevention counseling to identify triggers and coping alternatives; reassess treatment intensity and fit. [22] |
| Treatment started but engagement is fading | “What is keeping you in treatment, and what is making it harder to continue?” [22] | Reinforce internal reasons for continuing and consider external reinforcement strategies when available. [22][23] |
| Reports stigmatizing treatment experience | “What language, process, or prior interaction made care feel unsafe or disrespectful?” [1][24] | Repair the alliance, use person-first language, and revise the care pathway to preserve access. [1][8][24] |

## References
1. A systematic review of stigma interventions for providers who treat patients with substance use disorders — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0740547221002129
2. Shared decision‐making among people with problematic ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/dar.13149
3. Clinical Practice Guideline: Assessment and Treatment of Adolescents and Young Adults With Substance Use Disorders and Problematic Substance Use (Excluding Tobacco) — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0890856725014248
4. Motivational Interviewing - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/medicine-and-dentistry/motivational-interviewing
5. Health professions students' perspectives of a stigma ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S187613992400080X
6. Substance use disorders: a comprehensive update of ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1002/wps.21073
7. Depression, substance abuse and stigma among men who ... — journals.lww.com — https://journals.lww.com/aidsonline/_layouts/15/oaks.journals/downloadpdf.aspx?an=00002030-201512003-00008
8. Primary Care Guidance for Persons With HIV — www.idsociety.org — https://www.idsociety.org/practice-guideline/primary-care-management-of-people-with-hiv
9. Contingency management treatment for substance use disorders: How far has it come, and where does it need to go? — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC5714694
10. Motivational interviewing for substance use reduction - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10714668
11. EARLY INTERVENTION, TREATMENT, AND MANAGEMENT ... — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK424859
12. Chapter 3—Counseling Approaches for Promoting Harm ... — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK601490
13. Chapter 6—From Preparation to Action: Initiating Change - Enhancing Motivation for Change in Substance Use Disorder Treatment - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK571066
14. Contingency Management Approaches for Adolescent Substance Use Disorders — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC5019116
15. WHAT IS CONTINGENCY MANAGEMENT? - NCBI - NIH — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK606622
16. Motivational interviewing for substance abuse - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC8939890
17. Motivational interviewing for substance use reduction — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/38084817
18. The relationship between patient-centred care for substance use disorders and patient outcomes: A scoping review — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0955395925000696
19. Motivational interviewing—an evidence-based, collaborative, goal-oriented communication approach in lifestyle medicine: A comprehensive review of the literature — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S1658361223000550
20. Family-centered interventions for people with substance use disorders in low-and middle-income country settings: a scoping review — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0955395926001507
21. Academy of Nutrition and Dietetics and American Society ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2212267221003798
22. Chapter 7—From Action to Maintenance: Stabilizing Change - Enhancing Motivation for Change in Substance Use Disorder Treatment - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK571075
23. Contingency Management: Using Incentives to Improve ... - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC6834344
24. The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC9331017

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.